Skip to content

LifeStance Health Group LFST Cash & Equivalents

Cash & Equivalents at other companies

CVS Health logo
CVS HealthCVS
$9.77B-5.6%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
Universal Health Services logo
Universal Health ServicesUHS
$119.03M-6.1%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$163.4M+33.1%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$652.68M+47.9%
HCA Healthcare logo
HCA HealthcareHCA
$940M-11.3%

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04

Balance sheet

See full
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.43B-4.8%
Enterprise value$3.71B-6.5%
P/E147.8×
P/S2.3×-0.5×

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's cash & equivalents?
LifeStance Health Group (LFST) reported cash & equivalents of $194.8M in Q1 2026.
How has LifeStance Health Group's cash & equivalents changed year-over-year?
LifeStance Health Group's cash & equivalents increased by 45.0% year-over-year, from $134.34M to $194.8M.
What is the long-term trend for LifeStance Health Group's cash & equivalents?
Over 5 years (2020 to 2025), LifeStance Health Group's cash & equivalents has grown at a 67.6% compound annual growth rate (CAGR), from $18.83M to $248.64M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.